Searched for
PROLIA
Dr Reddy's gets European nod for biosimilar to treat osteoporosisProlia is a prescription medicine used to treat osteoporosis in women who have been through menopause and in men who are at increased risk ...24 Nov, 2025, 05.34 PM IST- Biocon shares rise 2% after USFDA approval for osteoporosis and bone loss drugsShares of Biocon Ltd rose 2% to Rs 361.25 on the BSE after its subsidiary, Biocon Biologics, received U.S. FDA approval for two denosumab b...18 Sep, 2025, 10.36 AM IST
- Aurobindo Pharma closing in on $5.5b Zentiva buyoutLargest Indian pharma M&A in final lap; PE firm GTCR only other contender. A portfolio company of Advent International, Zentiva will signif...20 Aug, 2025, 06.19 AM IST
- Alvotech, Dr. Reddy's ink pact for commercialisation of denosumabAlvotech and Dr. Reddy's partner for AVT03, a biosimilar to Prolia and Xgeva, treating osteoporosis and skeletal-related events. The agreem...21 May, 2024, 09.24 PM IST
- Lupin, DKSH enter pact to commercials Alvotech biosimilars in PhilippinesThe biosimilars planned under this agreement include biosimilar Prolia (denosumab 60mg/ml) and Xgeva (denosumab 70 mg/ml) for treating oste...07 Sep, 2022, 04.44 PM IST
- Dr Reddy's Laboratories inks pact with Amgen to commercialise three drugs in IndiaUnder the terms, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said...16 Sep, 2016, 05.02 PM IST
Load More
